i-SENS, Inc. (099190.KQ)
KRW 16060.0
(-3.37%)
KRW 16060.0
(-3.37%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 143.79 Billion KRW | 42.57% |
| 2022 | 100.85 Billion KRW | -0.02% |
| 2021 | 100.87 Billion KRW | 101.08% |
| 2020 | 50.16 Billion KRW | 37.33% |
| 2019 | 36.53 Billion KRW | -5.42% |
| 2018 | 38.62 Billion KRW | -8.09% |
| 2017 | 42.02 Billion KRW | 19.32% |
| 2016 | 35.22 Billion KRW | 25.58% |
| 2015 | 28.04 Billion KRW | -2.64% |
| 2014 | 28.8 Billion KRW | 26.21% |
| 2013 | 22.82 Billion KRW | 0.0% |
| 2012 | - KRW | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 176.98 Billion KRW | 22.26% |
| 2024 Q1 | 144.76 Billion KRW | 0.68% |
| 2023 Q4 | 143.79 Billion KRW | 6.0% |
| 2023 Q1 | 100.74 Billion KRW | -0.1% |
| 2023 Q2 | 111.91 Billion KRW | 11.08% |
| 2023 FY | 143.79 Billion KRW | 42.57% |
| 2023 Q3 | 135.65 Billion KRW | 21.21% |
| 2022 FY | 100.85 Billion KRW | -0.02% |
| 2022 Q1 | 100.66 Billion KRW | -0.2% |
| 2022 Q3 | 106.28 Billion KRW | 3.79% |
| 2022 Q4 | 100.85 Billion KRW | -5.11% |
| 2022 Q2 | 102.4 Billion KRW | 1.72% |
| 2021 FY | 100.87 Billion KRW | 101.08% |
| 2021 Q1 | 49.5 Billion KRW | 0.97% |
| 2021 Q2 | 47.98 Billion KRW | -3.07% |
| 2021 Q4 | 100.87 Billion KRW | 113.33% |
| 2021 Q3 | 47.28 Billion KRW | -1.46% |
| 2020 Q1 | 35.29 Billion KRW | -0.93% |
| 2020 Q3 | 50.69 Billion KRW | 50.15% |
| 2020 FY | 50.16 Billion KRW | 37.33% |
| 2020 Q4 | 49.03 Billion KRW | -3.28% |
| 2020 Q2 | 33.76 Billion KRW | -4.33% |
| 2019 Q1 | 38.49 Billion KRW | -0.33% |
| 2019 FY | 36.53 Billion KRW | -5.42% |
| 2019 Q3 | 37.51 Billion KRW | -1.84% |
| 2019 Q2 | 38.21 Billion KRW | -0.73% |
| 2019 Q4 | 35.62 Billion KRW | -5.04% |
| 2018 Q4 | 38.62 Billion KRW | -2.65% |
| 2018 Q1 | 40.94 Billion KRW | -2.56% |
| 2018 Q2 | 40.81 Billion KRW | -0.31% |
| 2018 FY | 38.62 Billion KRW | -8.09% |
| 2018 Q3 | 39.67 Billion KRW | -2.8% |
| 2017 Q4 | 42.02 Billion KRW | -5.15% |
| 2017 Q3 | 44.3 Billion KRW | -1.85% |
| 2017 Q1 | 32.68 Billion KRW | -7.21% |
| 2017 FY | 42.02 Billion KRW | 19.32% |
| 2017 Q2 | 45.14 Billion KRW | 38.13% |
| 2016 Q3 | 25.88 Billion KRW | -5.19% |
| 2016 FY | 35.22 Billion KRW | 25.58% |
| 2016 Q4 | 35.22 Billion KRW | 36.08% |
| 2016 Q2 | 27.29 Billion KRW | -0.63% |
| 2016 Q1 | 27.47 Billion KRW | -2.05% |
| 2015 Q2 | 28.64 Billion KRW | -0.25% |
| 2015 FY | 28.04 Billion KRW | -2.64% |
| 2015 Q1 | 28.71 Billion KRW | -0.3% |
| 2015 Q4 | 28.04 Billion KRW | 0.53% |
| 2015 Q3 | 27.89 Billion KRW | -2.62% |
| 2014 Q3 | 21.59 Billion KRW | -2.41% |
| 2014 FY | 28.8 Billion KRW | 26.21% |
| 2014 Q2 | 22.12 Billion KRW | -2.68% |
| 2014 Q4 | 28.8 Billion KRW | 33.42% |
| 2014 Q1 | 22.73 Billion KRW | -0.4% |
| 2013 Q1 | 9.78 Billion KRW | 0.0% |
| 2013 Q3 | 7.67 Billion KRW | -9.95% |
| 2013 Q4 | 22.82 Billion KRW | 197.52% |
| 2013 Q2 | 8.51 Billion KRW | -12.95% |
| 2013 FY | 22.82 Billion KRW | 0.0% |
| 2012 FY | - KRW | 0.0% |
| 2012 Q4 | - KRW | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Osang Healthcare Co.,Ltd | 697.79 Million KRW | -20506.436% |
| InBody Co.,Ltd | 6.08 Billion KRW | -2264.865% |
| Curexo Inc. | 2.05 Billion KRW | -6882.284% |
| Seegene, Inc. | 141.76 Billion KRW | -1.43% |
| Ray Co., Ltd. | 86.67 Billion KRW | -65.889% |
| Gencurix Inc. | 17.95 Billion KRW | -700.844% |
| Sugentech Inc. | 15.3 Billion KRW | -839.588% |
| L&C Bio Co., Ltd | 82.13 Billion KRW | -75.068% |